Study on the safety and effectiveness of mycobacterial phage cocktail spray for the treatment of smear-positive pulmonary tuberculosis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000035854

Enrollment

Unknown

Registered

2020-08-18

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tuberculosis

Interventions

A:only drugs

B:durgs+mycobacterial phages(spray,qd))

C:durgs+mycobacterial phages (spray, b.i.d)

D:durgs+mycobacterial phages (spray, t.i.d)

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent; 2. Sputum smear positive, GeneXpert positive, Rif sensitive; 3. Aged 18-65 years old; 4. Leave a fixed phone.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breastfeeding women; 2. Patients with severe primary disease or insufficiency of heart, liver, lungs and kidneys.

Design outcomes

Primary

Measure	Time frame
Adverse event rate;	—

Secondary

Measure	Time frame
EBA (Early Bactericidal Activity);	—

Countries

China

Contacts

Public ContactHuang Wei

Department of tuberculosis, Shanghai Public Health Clinical Center

huangweiwin@yeah.net+86 15988678976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026